From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.

WORST WEEK SINCE OCT.

U.S. markets had a downright awful week, with the Dow putting in its worst five-day stretch since October. The selloff started after the Federal Reserve moved up its forecast for interest rate hikes, saying it expects to do a pair in 2023 — an acknowledgment that the economy is recovering more quickly than the central bank predicted just a few months ago and that rising inflation threatens to slow that recovery down. Fed Chair Jerome Powell said the economy isn’t “out of the woods at this point” but that the labor market is looking strong. He also said inflation is rising faster than the Fed expected, and the Fed’s forecast now calls for 3.4 percent inflation in 2021, up from the prior estimate of 2.4 percent. That sent sectors like energy and industrials  that had been leading the recovery lower, with the broader market following suit. Then St. Louis Federal Reserve President James Bullard remarked that he expects the first rate hike to come as early as 2022. The S&P lost more than 1.5 percent on the week. 

VAX STOCKS SINK

The big COVID vaccine makers also had a miserable week, led by Novavax. The Maryland-based biotech fell 8 percent after reporting extremely positive results for its forthcoming vaccine, as investors looked to take profits on a stock that was at one point up close to 200 percent over the last year. BioNTech, Pfizer, and Moderna also fell on the Novavax news, given that they’re likely to face a new competitor in the market. Pfizer fell the least of the bunch; that stock has been remarkably steady despite being the first out of the gate with a life-saving vaccine that is helping to end a global pandemic. PFE shares are up just over 5 percent on the year while the S&P is up about 13 percent. 

SPACS TAKE NASDAQ

It was a fairly busy week for IPOs with two big names joining the Nasdaq. The cannabis review site Weedmaps and the at-home, genetic-testing powerhouse 23andMe both debuted on the exchange via SPACs. Weedmaps CEO Chris Beals said the company chose the SPAC route, merging with Silver Spike Acquisition Corp, in order to better “curate” its investor base. Weedmaps, which runs a SaaS platform for users to rate and buy from cannabis dispensaries in states where it’s legal — think Yelp for pot — received $579 million in a cash infusion in the deal. Meanwhile, 23andMe also went the SPAC route in its debut, merging with Richard Branson’s VG Acquisition Corp. in a deal that values the company at $3.5 billion. The stock spiked 21 percent on its first day of trade. 

HONEST EARNINGS 

Jessica Alba’s Honest Co. announced its first quarterly earnings release since going public, beating expectations on a narrower-than-expected loss and higher revenues, but showing signs of stagnation in some key areas. Honest’s diaper and wipes segment fell 2 percent year-over-year while digital sales rose just 2 percent, compared to 23 percent in the prior period. (The disappointing diaper sales were in line with Procter & Gamble’s numbers for its Pampers brand, for what it’s worth.) Honest has been branching out into new categories, which appears to be working. Sales of skin and personal care products and household and wellness products were up 42 and 53 percent year-over-year, respectively. The stock is trading roughly where it priced its IPO last month. 

BOTTLEGATE

The sponsors of the Euro 2020 soccer tournament are learning a valuable lesson about endorsements in the social media era. Shares of Coca-Cola slipped after Cristiano Ronaldo — one of the biggest soccer stars in the world with a social media following numbering half a billion — swapped two bottles of Coke for a bottle of water at his post-match press conference, urging people to drink “agua.” The clip immediately went viral online, wiping about $4 billion off Coke’s market cap and upsetting the delicate balance of power between superstars and brands in the online era. (Ronaldo started a bit of a trend at the Euro; Italian star Manuel Locatelli copied his move with the Coke bottles, and Manchester United’s Paul Pogba removed a strategically placed bottle of Heineken beer from his presser.) Coke, of course, is too big to feel much long-term pain from a fleeting viral video; the beverage giant said in April its global case volume is already back to pre-pandemic levels and the stock is up more than 15 percent in the last year.

Share:
More In Business
Pandemic Leads to Seismic Shift in Labor Market
Marjorie Mesidor, Partner at Phillips & Associates, joined Wake Up With Cheddar to break down the latest trends in the job market, as the demand for labor has recovered, but as the number of people willing to fill positions remains relatively low.
A Year of Highs and Lows for Crypto in 2021
2021 proved that crypto currency is here to stay. This year saw more and more adoptions of crypto, from top athletes looking to be paid in bitcoin, to Elon Musk even experimenting with bitcoin and dogecoin payments for a bit over at Tesla. And it wasn't all bitcoin either - other cryptos like Cardano and Solana saw some action in 2021 as well. Patrick McConlogue, CEO of Overline and former Citadel Investment Group Engineer explains why 2021 was such a good year for crypto, and what to expect in 2022.
2022 Promises a Mixed Bag of Market Predictions
2021 saw markets continue to be impacted by the onslaught of the coronavirus pandemic -most recently in the form of the Omicron variant- in addition to the global supply chain shortage, and increased inflation. But it wasn't all bad news, as crypto soared throughout the year, and meme stocks continued to have a moment. With the year coming to a close, investors are keeping an eye out to see if they should expect more of the same in the new year. Chris Vecchio, Senior Analyst, at DailyFX tells us what market trends to be on the watch for in 2022.
Under Threaten of Competition, Tesla Held Its Own in 2021
2021 proved to be yet another formidable year for Tesla. In a year that saw electric vehicles carve out their own space in the transportation world, the company made further strides, keeping its spot on top even as new companies threatened competition. Tesla was able to hit the trillion dollar valuation mark, increase vehicle deliveries even as the world grappled with supply chain and delivery issues and sign a major deal with Hertz this year. And of course, you can't talk about Tesla without talking about Elon Musk, CEO and founder of the company, richest man in the world and Time Magazine Person of the Year, who saw plenty of successes in 2021 as well. Al Root, Senior Writer at Barron’s, explains just how good a year it was for Tesla.
U.S. Home Prices Climb 18.4% in October Compared to Last Year
The S&P CoreLogic Case-Shiller 20-city home price index showed an 18.4 percent surge in October as the housing market continues to boom. October's levels are a slight downturn from the roughly 19 percent increase the index saw in September, but come roughly in line with economist expectations. Michael J. Romer, Managing Partner, Romer Debbas joined Wake Up with Cheddar to discuss.
Thousands of U.S. Flights Cancelled Due to Omicron Spike, Labor Shortages
U.S. airlines have canceled more than 6,000 flights since Christmas eve, causing headaches for travelers. Airlines cited staffing shortages amid the omicron outbreak as the primary reason for the interruptions to service. The cancellations come at the busiest time of year for air travel. Steve Shur, President, The Travel Technology Association joined Wake Up with Cheddar to discuss.
Experts Warn Pfizer, Merck COVID-19 Treatments Need Careful Supervision
Dr. Soumi Eachempati, co-founder and CEO of Cleared4 and former professor of surgery and public health at Weill Cornell Medical College, joined Cheddar to breakdown what people should know about the recently FDA-approved emergency use of Merck and Pfizer's COVID-19 treatment pills. He noted that not only do people need to be aware of other medications they are taking that could cause adverse effects if coupled with COVID-19 pill treatments, he also talked about the intense in-take regiment. "The Merck pills are actually about 40 pills over five days. The Pfizer ones are three pills over five days, so people have to be prepared for that because it is a lot of pills you'll have to take to get full value from these drugs," Eachempati told Cheddar.
World's Largest Dispensary Planet 13 Plans Cannabis Consumption Lounge
Adult-use cannabis sales kicked off in Nevada in 2017, but four years later, there isn’t a legal way for the 40 million tourists who visit the state annually to consume. That’s all about to change. Following the passage in June of a bill to legalize consumption lounges, the world’s largest dispensary, Planet 13, is planning a cannabis club as extravagant as Las Vegas. Cheddar’s Chloe Aiello visited the cannabis entertainment complex to find out more.
Load More